-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Corteva, Lowers Price Target to $85

Benzinga·08/18/2026 13:58:39
Listen to the news
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $89 to $85.